Amniotic membrane market seen reaching $3.15 billion by 2030

The amniotic membrane market is projected to grow from $1.88 billion in 2025 to $3.15 billion by 2030, driven by wider use in wound care, ophthalmology and regenerative medicine. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - The amniotic membrane market is moving from niche tissue applications toward broader use in wound healing, regenerative medicine and surgical recovery. - Rising transplant volumes, chronic disease burden and expanding outpatient procedures are expected to keep demand climbing through 2030.

What happened: - The Business Research Company said the global amniotic membrane market will rise from $1.88 billion in 2025 to $2.09 billion in 2026. - The report projects the market will reach $3.15 billion by 2030. - The report covers market size, trends and forecasts for 2026-2035. - The company released a sample report and full report links with additional market data. - Download the sample report - View the full report

The details: - The market is forecast to grow at a 10.8% CAGR from 2025 to 2026. - The market is forecast to grow at a 10.9% CAGR from 2026 to 2030. - Historical growth has been driven by regenerative medicine research, surgical wound care, ophthalmology adoption, improved tissue preservation and biologic treatments in hospitals. - Future growth is expected to come from demand for advanced wound healing products, minimally invasive surgery, outpatient surgeries, biologic therapies and clearer regulations for tissue-based products. - The report flags broader use in regenerative treatments, greater incorporation in ophthalmic surgeries, expansion in wound care, stronger preference for cryopreserved products and tighter biological safety standards. - The amniotic membrane is the innermost layer of the placenta, with an avascular stromal matrix and a thick foundational membrane. - Clinically, the tissue is used as a dressing across multiple surgical specialties to support wound healing and reduce inflammation. - Transplant surgeries are a major growth driver because amniotic membrane allografts can support tissue repair and recovery. - The Organ Procurement and Transplantation Network reported 46,632 organ transplants in the U.S. in 2023, up 8.7% from 2022. - The Organ Procurement and Transplantation Network also reported 41,119 deceased-donor transplants in early 2024, up 3.6%. - Chronic disease growth is another demand driver because the membrane’s anti-inflammatory and regenerative qualities can help manage chronic conditions and tissue damage. - The World Health Organization projected new cancer cases worldwide will exceed 35 million by 2050, up 77% from 20 million in 2022. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow the fastest over the forecast period. - The analysis also includes South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast points to a market shift from established clinical use toward wider adoption in specialized procedures and biologic therapies. - Faster growth in Asia-Pacific suggests healthcare investment and expanding clinical infrastructure may be closing the gap with North America. - The emphasis on cryopreserved products and biological safety standards signals a market that is becoming more regulated and quality-focused.

What's next: - The market is expected to benefit from continued transplant growth, rising chronic disease cases and expanded use in ophthalmology and wound care. - Product development will likely center on regenerative applications, preservation methods and compliance with tissue-product regulations. - The Business Research Company says the report includes market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, market hotspot infographics, and technology and trend analysis. - The company also provided contact details for expert inquiries and follow-up conversations.